Vanderbilt University Medical Center Henry-Joyce Cancer Clinic (Adults and Pediatrics) is a clinical research site located in Nashville, Tennessee, United States 37232.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Vanderbilt University Medical Center Henry-Joyce Cancer Clinic (Adults and Pediatrics) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders.
Sponsors: Pierre Fabre Medicament.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Vanderbilt University Medical Center Henry-Joyce Cancer Clinic (Adults and Pediatrics) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Vanderbilt University Medical Center Henry-Joyce Cancer Clinic (Adults and Pediatrics) has 1 clinical trials on record, with 1 currently active. Their work covers Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders.
Vanderbilt University Medical Center Henry-Joyce Cancer Clinic (Adults and Pediatrics) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.